The store will not work correctly when cookies are disabled.
(5-hydroxy-3-phenyl-5-(trifluoromethyl)-4,5-dihydro-1H-pyrazol-1-yl)(pyridin-4-yl)methanone
ID: ALA5266978
Max Phase: Preclinical
Molecular Formula: C16H12F3N3O2
Molecular Weight: 335.29
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(c1ccncc1)N1N=C(c2ccccc2)CC1(O)C(F)(F)F
Standard InChI: InChI=1S/C16H12F3N3O2/c17-16(18,19)15(24)10-13(11-4-2-1-3-5-11)21-22(15)14(23)12-6-8-20-9-7-12/h1-9,24H,10H2
Standard InChI Key: VZYZZSKFUMNZLJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
1.1741 -1.3069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8886 -0.8946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6004 -1.3065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6004 -2.1317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8904 -2.5435 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1741 -2.1354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8886 -0.0694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1740 0.3431 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6032 0.3431 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.4206 0.0076 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1313 0.6206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2809 1.3349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0878 1.1633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9560 0.6206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3686 -0.0934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1908 -0.0927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6032 0.6215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1943 1.3331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3701 1.3378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8858 1.3772 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3021 1.9596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7196 2.5435 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.8853 2.5428 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.0987 1.7463 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
2 7 1 0
7 8 1 0
7 9 2 0
10 8 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 8 1 0
14 11 1 0
15 14 2 0
16 15 1 0
17 16 2 0
18 17 1 0
14 19 1 0
19 18 2 0
13 20 1 0
13 21 1 0
21 22 1 0
21 23 1 0
21 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 335.29 | Molecular Weight (Monoisotopic): 335.0882 | AlogP: 2.58 | #Rotatable Bonds: 2 |
Polar Surface Area: 65.79 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.07 | CX Basic pKa: 2.89 | CX LogP: 2.58 | CX LogD: 2.57 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.92 | Np Likeness Score: -1.26 |
References
1. Koike T, Yoshikawa M, Ando HK, Farnaby W, Nishi T, Watanabe E, Yano J, Miyamoto M, Kondo S, Ishii T, Kuroita T.. (2021) Discovery of Soticlestat, a Potent and Selective Inhibitor for Cholesterol 24-Hydroxylase (CH24H)., 64 (16.0): [PMID:34387987] [10.1021/acs.jmedchem.1c00864] |